# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Nordson Corporation (NASDAQ:NDSN) has completed the divestiture of select product lines within its medical contract manufacturi...
Oppenheimer analyst Christopher Glynn maintains Nordson (NASDAQ:NDSN) with a Outperform and raises the price target from $26...
Baird analyst Michael Halloran maintains Nordson (NASDAQ:NDSN) with a Neutral and raises the price target from $245 to $252.
Technology stocks on the Nasdaq 100 were poised for a third consecutive day of losses Thursday, as investors continued to adopt...